anmelden
OMX Nordic 40
2.633,94
PKT
+21,52
PKT
+0,82
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.12.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 06.12.19 | Novo Nordisk Neutral | UBS AG | |
| 05.12.19 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 03.12.19 | AstraZeneca Sell | UBS AG | |
| 28.11.19 | A.P. Moeller - Maersk A-S (B) Underweight | JP Morgan Chase & Co. | |
| 27.11.19 | AstraZeneca Reduce | HSBC | |
| 27.11.19 | Novo Nordisk Reduce | HSBC | |
| 25.11.19 | A.P. Moeller - Maersk A-S (B) buy | Kepler Cheuvreux | |
| 22.11.19 | AstraZeneca overweight | Barclays Capital | |
| 22.11.19 | A.P. Moeller - Maersk A-S (B) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.11.19 | Novo Nordisk Hold | Deutsche Bank AG | |
| 21.11.19 | Novo Nordisk Neutral | UBS AG | |
| 21.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 19.11.19 | A.P. Moeller - Maersk A-S (B) verkaufen | Barclays Capital | |
| 18.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.11.19 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
| 18.11.19 | Novo Nordisk Neutral | UBS AG | |
| 18.11.19 | Novo Nordisk overweight | Barclays Capital | |
| 15.11.19 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
| 15.11.19 | ABB (Asea Brown Boveri) buy | HSBC | |
| 12.11.19 | AstraZeneca buy | Deutsche Bank AG | |
| 12.11.19 | Volvo (B) Underweight | Morgan Stanley | |
| 11.11.19 | AstraZeneca Sell | UBS AG | |
| 11.11.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 11.11.19 | Novo Nordisk Hold | Deutsche Bank AG | |
| 11.11.19 | Nokia Sell | Goldman Sachs Group Inc. | |
| 08.11.19 | Ericsson (Telefon L.M.Ericsson) (B) overweight | Morgan Stanley | |
| 08.11.19 | Nokia Equal-Weight | Morgan Stanley | |
| 08.11.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 07.11.19 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 07.11.19 | AstraZeneca buy | Deutsche Bank AG | |
| 06.11.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 06.11.19 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 06.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.11.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 04.11.19 | Novo Nordisk Equal weight | Barclays Capital | |
| 04.11.19 | Novo Nordisk Hold | Deutsche Bank AG | |
| 04.11.19 | Novo Nordisk Outperform | Bernstein Research | |
| 04.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. |